The new capsule is electronically-augmented swallowable capsule that allows patients and physicians to know if any doses are missed, according to a report published on March 29, 2019.
This new capsule is part of the ID-Cap system that was developed by etectRx, which is a company based in Florida. ID-Cap system consists of the gelatine ID-Capsule, the electronic ID-Tag that sits curled up inside the capsule, and the externally-worn ID-Cap Reader device.
The ID-Capsule contains medication and can be swallowed like any other pharmaceutical capsule. When the capsule is dissolved within the digestive tract, the medication and the ID-Tag are released. A chemical reaction takes place with the stomach fluids during which the tag proceeds to emit a low-power radio signal. The Reader picks up the signal, which is worn against the chest on a lanyard.
The Reader has a Bluetooth module, with which it can wirelessly notify an app on the user's smartphone, thereby confirming that the capsule has been swallowed. Patients and their doctors can track the ‘patient ingestion events’ in real-time, as the app is connected to the internet. If the patient misses any dose, it will be displayed on the dashboard. This technology is currently awaiting for approval form the U.S. Food and Drug Administration.
In the meantime, it will be the subject of a 90-day study being conducted in partnership with Harvard-affiliated Brigham and Women's Hospital, and the Fenway Institute at Fenway Health. According to officials of etectRX, “The purpose of the study is to examine medication adherence patterns and understand how adherence can be increased among populations at risk for HIV infection.”
Subscribe to our newsletter to get notification about new updates,information, discount, etc..